Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Axonics Inc (AXNX)

Axonics Inc (AXNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Axonics: Q1 Earnings Snapshot

Axonics: Q1 Earnings Snapshot

AXNX : 67.20 (-0.21%)
Axonics: Q4 Earnings Snapshot

Axonics: Q4 Earnings Snapshot

AXNX : 67.20 (-0.21%)
Why Axonics Stock Soared Today

The medical device maker agreed to be acquired by Boston Scientific.

AXNX : 67.20 (-0.21%)
BSX : 76.76 (-0.26%)
Axonics: Q3 Earnings Snapshot

Axonics: Q3 Earnings Snapshot

AXNX : 67.20 (-0.21%)
Why Shares of Axonics Rose Friday

The company showed improved revenue and margins in its second-quarter report.

MDT : 81.04 (-0.76%)
AXNX : 67.20 (-0.21%)
Axonics: Q2 Earnings Snapshot

Axonics: Q2 Earnings Snapshot

AXNX : 67.20 (-0.21%)
Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 44.12% and 9.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AXNX : 67.20 (-0.21%)
HCAT : 6.46 (+2.22%)
Axonics: Q1 Earnings Snapshot

Axonics: Q1 Earnings Snapshot

AXNX : 67.20 (-0.21%)
Axonics Reports First Quarter 2023 Financial Results

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results...

AXNX : 67.20 (-0.21%)
Axonics to Participate in Upcoming Investor Conferences

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in...

AXNX : 67.20 (-0.21%)

Barchart Exclusives

3 Highest-yielding Tech Stocks to Buy Now
Tech stocks aren't famous for paying dividends. There are, however, a select few that do. Here are the top 3 based on yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar